Related references
Note: Only part of the references are listed.The FAcilitates Chromatin Transcription (FACT) complex: Its roles in DNA repair and implications for cancer therapy
Kishor K. Bhakat et al.
DNA REPAIR (2022)
Atherosclerosis: Recent developments
Johan L. M. Bjoerkegren et al.
CELL (2022)
Mouse models of atherosclerosis in translational research
Iqra Ilyas et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Stimulation of an anti-tumor immune response with chromatin-damaging therapy
Minhui Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
The changing landscape of atherosclerosis
Peter Libby
NATURE (2021)
Global epidemiology of dyslipidaemias
Angela Pirillo et al.
NATURE REVIEWS CARDIOLOGY (2021)
Targeting inflammation in atherosclerosis - from experimental insights to the clinic
Oliver Soehnlein et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3
Dan Wang et al.
NATURE COMMUNICATIONS (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Focal TLR4 activation mediates disturbed flow-induced endothelial inflammation
Dan Qu et al.
CARDIOVASCULAR RESEARCH (2020)
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia
Klaartje Somers et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Laminar flow inhibits the Hippo/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis
Ping Yuan et al.
CELL DEATH & DISEASE (2020)
Src mediates β-adrenergic receptor induced YAP tyrosine phosphorylation
Wenjing Wang et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis
Mingming Liu et al.
CELL REPORTS (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
CBL0137 administration suppresses human hepatocellular carcinoma cells proliferation and induces apoptosis associated with multiple cell death related proteins
M. A. H. Albahde et al.
NEOPLASMA (2020)
c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow
Bochuan Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Curaxin CBL0137 has the potential to reverse HIV-1 latency
Maxime J. Jean et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
The Global Burden of Cardiovascular Diseases and Risk Factors 2020 and Beyond
George A. Mensah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
ACTL6A interacts with p53 in acute promyelocytic leukemia cell lines to affect differentiation via the Sox2/Notch1 signaling pathway
Peng-Qiang Zhong et al.
CELLULAR SIGNALLING (2019)
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
John M. Lamar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation
Rory L. Smoot et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by Increasing NOTCH1 Expression and Targeting Tumor-Initiating Cells
Sarmishtha De et al.
CANCER RESEARCH (2018)
YAP Controls Endothelial Activation and Vascular Inflammation Through TRAF6
Yang Lv et al.
CIRCULATION RESEARCH (2018)
Curaxin CBL0137 Exerts Anticancer Activity via Diverse Mechanisms
Ming-Zhu Jin et al.
FRONTIERS IN ONCOLOGY (2018)
Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide- responsive and - resistant glioblastoma
Tara A. Barone et al.
NEURO-ONCOLOGY (2017)
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program
Richard Lock et al.
PEDIATRIC BLOOD & CANCER (2017)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological Basis of CANTOS and Beyond
Peter Libby
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Level of FACT defines the transcriptional landscape and aggressive phenotype of breast cancer cells
Daria Fleyshman et al.
ONCOTARGET (2017)
Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas
Minhyung Kim et al.
CANCER RESEARCH (2016)
Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models
Josephine Kam Tai Dermawan et al.
CANCER RESEARCH (2016)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Michael A. Gimbrone et al.
CIRCULATION RESEARCH (2016)
αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway
Peng Li et al.
GENES & DEVELOPMENT (2016)
Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow
Li Wang et al.
NATURE (2016)
Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis
Kuei-Chun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells
Suowen Xu et al.
TRANSLATIONAL RESEARCH (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
A gp130-Src-YAP module links inflammation to epithelial regeneration
Koji Taniguchi et al.
NATURE (2015)
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer
Catherine Burkhart et al.
ONCOTARGET (2014)
Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility
Han Xiao et al.
CIRCULATION (2013)
The Hippo pathway: regulators and regulations
Fa-Xing Yu et al.
GENES & DEVELOPMENT (2013)
Association of Coronary Wall Shear Stress With Atherosclerotic Plaque Burden, Composition, and Distribution in Patients With Coronary Artery Disease
Parham Eshtehardi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Curaxins: Anticancer Compounds that Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT
Alexander V. Gasparian et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Yap1 phosphorylation by c-AbI is a critical step in selective activation of proapoptotic genes in response to DNA damage
Dan Levy et al.
MOLECULAR CELL (2008)
Share Paper
